Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
| Cluster id | Level | Cluster label | #P |
|---|---|---|---|
| 10 | 4 | IMMUNOLOGY//TRANSPLANTATION//RHEUMATOLOGY | 1369268 |
| 255 | 3 | IMMUNOLOGY//CELLULAR IMMUNOLOGY//JOURNAL OF IMMUNOLOGY | 46035 |
| 2637 | 2 | CANCER IMMUNOLOGY IMMUNOTHERAPY//NEWCASTLE DISEASE VIRUS//ANTITUMOR RESISTANCE | 3739 |
| 17009 | 1 | NEWCASTLE DISEASE VIRUS//ACTIVE SPECIFIC IMMUNOTHERAPY//VIRAL ONCOLYSATE | 649 |
Terms with highest relevance score |
| rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|---|
| 1 | NEWCASTLE DISEASE VIRUS | authKW | 388889 | 12% | 11% | 76 |
| 2 | ACTIVE SPECIFIC IMMUNOTHERAPY | authKW | 179563 | 2% | 26% | 14 |
| 3 | VIRAL ONCOLYSATE | authKW | 155393 | 1% | 80% | 4 |
| 4 | AF2240 | authKW | 145682 | 0% | 100% | 3 |
| 5 | MTH 68 H | authKW | 145682 | 0% | 100% | 3 |
| 6 | VACCINIA MELANOMA ONCOLYSATE | authKW | 145682 | 0% | 100% | 3 |
| 7 | CELLULAR IMMUNOL | address | 138047 | 8% | 5% | 54 |
| 8 | RECOMBINANT NEWCASTLE DISEASE VIRUS | authKW | 134470 | 1% | 46% | 6 |
| 9 | TUMOR CELL VACCINES | authKW | 121397 | 1% | 50% | 5 |
| 10 | CELLULAR IMMUNOL D010 | address | 109260 | 0% | 75% | 3 |
Web of Science journal categories |
| chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | Oncology | 7712 | 56% | 0% | 365 |
| 2 | Immunology | 1193 | 22% | 0% | 140 |
| 3 | Medicine, Research & Experimental | 1017 | 16% | 0% | 102 |
| 4 | Virology | 452 | 7% | 0% | 44 |
| 5 | Biotechnology & Applied Microbiology | 103 | 7% | 0% | 44 |
| 6 | Surgery | 33 | 6% | 0% | 40 |
| 7 | Pharmacology & Pharmacy | 29 | 7% | 0% | 43 |
| 8 | Radiology, Nuclear Medicine & Medical Imaging | 24 | 4% | 0% | 24 |
| 9 | Genetics & Heredity | 24 | 4% | 0% | 26 |
| 10 | CYTOLOGY & HISTOLOGY | 22 | 0% | 0% | 2 |
Address terms |
| chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | CELLULAR IMMUNOL | 138047 | 8% | 5% | 54 |
| 2 | CELLULAR IMMUNOL D010 | 109260 | 0% | 75% | 3 |
| 3 | ABT 0710 | 97122 | 0% | 100% | 2 |
| 4 | ABT ZELLULARE IMMUNOL G0100 | 97122 | 0% | 100% | 2 |
| 5 | BIOPHARMACEUT TEACHING | 97122 | 0% | 100% | 2 |
| 6 | ABT ZELLULARE IMMUNOL | 64746 | 0% | 67% | 2 |
| 7 | 220 SANTA MONICA BLVD | 48561 | 0% | 100% | 1 |
| 8 | ABT DERMTOL | 48561 | 0% | 100% | 1 |
| 9 | AFFILIATE HOSP 4 | 48561 | 0% | 100% | 1 |
| 10 | BIOCHEMCHANOCK VIROL | 48561 | 0% | 100% | 1 |
Journals |
| chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | CANCER IMMUNOLOGY IMMUNOTHERAPY | 22134 | 7% | 1% | 45 |
| 2 | CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS | 18878 | 4% | 2% | 24 |
| 3 | INTERNATIONAL JOURNAL OF ONCOLOGY | 8744 | 6% | 0% | 42 |
| 4 | CANCER BIOTHERAPY | 4595 | 0% | 3% | 3 |
| 5 | JOURNAL OF BIOLOGICAL RESPONSE MODIFIERS | 2483 | 1% | 1% | 5 |
| 6 | YAKHTEH | 1345 | 0% | 1% | 2 |
| 7 | BIKEN JOURNAL | 1300 | 0% | 1% | 2 |
| 8 | CANCER GENE THERAPY | 1204 | 1% | 0% | 7 |
| 9 | CANCER RESEARCH | 1070 | 5% | 0% | 30 |
| 10 | SEMINARS IN SURGICAL ONCOLOGY | 896 | 1% | 0% | 4 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 1 |